N@N

AKRX, KFRC, BKI, BCPC, IPGP, RIGL Expected To Be Higher After Earnings Releases on Tuesday

^{Published on 2010-08-02 08:09:57, Last Modified on 2010-12-22 18:36:25 - WOPRAI}
 

August 2, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, August 3rd and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports. Akorn (NASDAQ: AKRX), Kforce (NASDAQ: KFRC), Buckeye Technologies (NYSE: BKI), Balchem (NASDAQ: BCPC), IPG Photonics (NASDAQ: IPGP) and Rigel Pharmaceuticals (NASDAQ: RIGL) are all expected to be higher after their earnings are released Tuesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher after earnings are released Tuesday:

Symbol Company # of Reports Quarter Release Time

AKRX Akorn Inc. 12 quarters Q2 Before

KFRC Kforce, Inc. 12 quarters Q2 After

BKI Buckeye Technologies 12 quarters Q4 After

BCPC Balchem Corp 12 quarters Q2 During

IPGP IPG Photonics Corp 12 quarters Q2 Before

RIGL Rigel Pharmaceuticals August earnings Q2 Before

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Akorn, Inc. (NASDAQ: AKRX) manufactures and markets diagnostic and therapeutic pharmaceuticals in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States. The companya�s Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting. It also sells therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers. The companya�s Hospital Drugs & Injectables segment markets hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, and controlled substances for pain management and anesthesia; and other pharmaceutical products. This segment markets products to hospitals through the wholesale distribution channel. Its Contract Services segment manufactures ophthalmic and injectable pharmaceutical products for third party pharmaceutical customers. The companya�s customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, and other pharmaceutical companies. It has strategic partnerships with Strides Arcolab Limited; Serum Institute of India, Ltd.; Hameln Pharmaceuticals; and Cipla, Ltd. The company was founded in 1971 and is headquartered in Lake Forest, Illinois.

Kforce Inc. (NASDAQ: KFRC), together with its subsidiaries, provides professional and technical specialty staffing services and solutions to the federal government, state and local governments, local and regional companies, and small to mid-sized companies in the United States. It offers flexible staffing services and solutions on temporary and full-time basis, as well as provides search services. The company operates in four segments: Technology, Finance and Accounting, Health and Life Sciences, and Government Solutions. The Technology segment offers systems/applications programmers, systems analysts, enterprise data management, and e-business and networking technicians in the areas of information technologies. The Finance and Accounting segment provides temporary staffing and search placement services to clients in areas, such as taxation, budget preparation and analysis, financial reporting, cost analysis, accounts payable, accounts receivable, professional administrative, credit and collections, general accounting, audit services, systems and controls analysis, and documentation to support compliance work. The Health and Life Sciences segment offers clinical research associates for the pharmaceutical industry; and health care information management professionals and nurses for hospitals and healthcare facilities. The Government Solutions segment provides finance and accounting, and technology professionals to the federal government primarily as a prime contractor. The company was founded in 1994 and is headquartered in Tampa, Florida.

Buckeye Technologies Inc. (NYSE: BKI) manufactures and distributes cellulose-based specialty products made from wood and cotton worldwide. The companya�s products include chemical cellulose, customized fibers, fluff pulp, and nonwoven materials. Its chemical cellulose is used in the manufacture of various products, including food casings, cigarette filters, rayon filaments, acetate fibers, and thickeners for consumer products, cosmetics, and pharmaceuticals. The companya�s customized fibers are used to provide porosity, color permanence, and tear resistance in filters, letterheads, currency papers, and personal stationery, as well as absorbency and softness in cotton balls and cotton swabs. Its fluff pulp and nonwoven materials are used to increase absorbency and fluid transport in products, such as disposable diapers, feminine hygiene products, and adult incontinence products, as well as used to enhance fluid management and strength in wipes, tabletop items, food pads, household wipes, and mops. The company was founded in 1992 and is headquartered in Memphis, Tennessee.

Balchem Corporation (NASDAQ: BCPC) provides specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. The companya�s Specialty Products segment offers ethylene oxide, which is used to sterilize a range of medical devices; ethylene oxide blends that are used in killing bacteria, fungi, and insects in spices and other seasoning materials; and propylene oxide, which is used for fumigation in spice treatment and in various chemical synthesis applications. Its Food, Pharma & Nutrition segment provides microencapsulation, granulation, and agglomeration solutions to a range of applications in food, pharmaceutical, and nutritional ingredients. These solutions are used in baked goods, refrigerated and frozen dough systems, processed meats, seasoning blends, confections, and nutritional supplements. This segment also offers choline nutrient products for wellness applications; and granulated calcium carbonate products for the treatment of osteoporosis, gastric disorders, and calcium deficiencies. The companya�s Animal Nutrition & Health segment provides various nutritional products consisting of REASHURE Choline, an encapsulated choline product; NITROSHURETM, an encapsulated urea supplement; and NIASHURETM, its microencapsulated niacin product for dairy cows and milk production. This segment also offers chelated mineral supplements for use in animal feed; choline chloride, a nutrient for animal health; and methylamines for the manufacture of choline products, and also used in a range of industrial applications. Balchem Corporation sells its products through its own sales force, independent distributors, and sales agents. The company was founded in 1967 and is headquartered in New Hampton, New York.

IPG Photonics Corporation (NASDAQ: IPGP) manufactures fiber lasers and amplifiers for use in a range of markets, such as materials processing, advanced technologies, telecommunications, and medical applications. The company offers optical fiber-based lasers, which combine the advantages of semiconductor diodes with the high amplification and precise beam qualities of specialty optical fibers. It also provides packaged diodes, direct diode laser systems, and communications systems that utilize its optical fiber-based products. Its fiber lasers are used in materials processing applications, such as marking, printing, welding, cutting, micromachining, surface treatment, drilling, soldering, annealing, rapid prototyping, and laser-assisted machining. The companya�s fiber lasers and amplifiers are utilized by commercial firms, and academic and government institutions for manufacturing commercial systems and for research in advanced technologies and products. In addition, IPG Photonics Corporation designs and manufactures a DWDM transport system, a range of fiber amplifiers, and Raman pump lasers that enhance data transmission in broadband access and DWDM optical networks. The companya�s commercial fiber and diode lasers are incorporated into medical laser systems that are used in skin rejuvenation, skin resurfacing, and stretch mark removal applications; and diode lasers are used in dental, skin tightening, and fat melting procedures, as well as in prostate surgery. IPG Photonics Corporation sells its products to original equipment manufacturers, system integrators, and end users through direct sales force, as well as through agreements with independent sales representatives and distributors worldwide. The company was founded in 1990 and is headquartered in Oxford, Massachusetts.

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The companya�s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641